Skip to main content
logo
Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 30, 2026

Windtree Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-15.75-24.52-17.34-21.49-32.26-29.42
Net Income
-48.83-5.49-20.29-39.21-67.64-32.57
Earnings Per Share
-5.90-104.35----
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.21.784.326.1722.3516.93
Total Debt
3.491.4916.8317.2817.8918.78
Net Cash (Debt)
-3.280.29-12.51-11.114.46-1.85
Net Cash Growth
------
Net Cash Per Share
-0.405.42----

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-15.12-15.4-13.44-19.45-23.66-25.32
Capital Expenditures
--0.01-0.02-0.01-0.28-0.29
Free Cash Flow
-15.12-15.41-13.45-19.47-23.94-25.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
------